<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">T8VDZH8qHBKhzTVLxd6zSbL</article-id>
      <article-id pub-id-type="other">00009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011000900009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09700109</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000067</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A velocidade da onda de pulso em jovens: estudo do Rio de Janeiro</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pizzi</surname>
            <given-names>Oswaldo Luiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Andr&#233;a Araujo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pozzan</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magalh&#227;es</surname>
            <given-names>Maria Eliane Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freitas</surname>
            <given-names>Elizabete Viana de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Ayrton Pires</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade do Estado do Rio de Janeiro</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Petr&#243;polis</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdade de Medicina de Petr&#243;polis</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2011</year>
      </pub-date>
      <volume>97</volume>
      <issue>1</issue>
      <fpage>53</fpage>
      <lpage>58</lpage>
      <history>
        <date date-type="rev-recd">
          <day>11</day>
          <month>11</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>18</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>02</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A velocidade da onda de pulso (VOP) pode ser marcador de comprometimento cardiovascular, por&#233;m existem poucos estudos em adultos jovens. OBJETIVO: Avaliar a associa&#231;&#227;o da press&#227;o arterial (PA), vari&#225;veis antropom&#233;tricas e metab&#243;licas, atuais e obtidas 13 anos antes, na inf&#226;ncia e adolesc&#234;ncia, com a VOP. M&#201;TODOS: Sessenta indiv&#237;duos foram acompanhados longitudinalmente e estratificados em dois grupos segundo o percentil da press&#227;o arterial (PA) obtido 13 anos antes: Grupo 1 (G1): percentil da PA &lt; 50 (n = 25, 11M, 26,4 anos) e Grupo 2 (G2): percentil da PA &gt; 95 (n = 35, 19M, 25,4 anos). Foram submetidos a avalia&#231;&#227;o cl&#237;nica, an&#225;lise laboratorial e medidas da VOP pelo m&#233;todo Complior. RESULTADOS: G1 apresentou maior m&#233;dia de idade; G2 exibiu maior m&#233;dia de: peso, PA sist&#243;lica (PAS), PA diast&#243;lica (PAD), PA m&#233;dia (PAM), VOP e glicemia, e menor m&#233;dia de HDL-colesterol. PAS, PAM e frequ&#234;ncia card&#237;aca (FC) obtidas na inf&#226;ncia e adolesc&#234;ncia apresentaram correla&#231;&#227;o significativa com a VOP. Peso, altura, cintura, rela&#231;&#227;o cintura/quadril, PAS, PAD, press&#227;o de pulso (PP), PAM e creatinina atuais apresentaram correla&#231;&#227;o positiva e significativa com a VOP. A compara&#231;&#227;o das m&#233;dias de VOP ajustadas pela PAS, PAD, PAS e PAD, PAM e PP n&#227;o mostrou diferen&#231;a estatisticamente significativa entre os grupos. CONCLUS&#195;O: O percentil da PA na inf&#226;ncia/adolesc&#234;ncia mostrou-se relacionado &#224; distensibilidade arterial, avaliada pela VOP, 13 anos ap&#243;s. Altera&#231;&#245;es da VOP podem ser identificadas em indiv&#237;duos jovens, sugerindo que o comprometimento vascular precoce pode estar presente nessa faixa et&#225;ria, relacionado tamb&#233;m a press&#227;o arterial, vari&#225;veis antropom&#233;tricas e metab&#243;licas.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Velocidade do fluxo sangu&#237;neo</kwd>
        <kwd>press&#227;o arterial</kwd>
        <kwd>&#237;ndice de massa corporal</kwd>
        <kwd>adolescente</kwd>
        <kwd>Brasil</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>27</day>
        <month>05</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>A velocidade da onda de pulso em jovens. Estudo do Rio de Janeiro</bold>
    </p>
    <p>
      <bold>Oswaldo Luiz Pizzi<sup>I</sup>; Andr&#233;a Araujo Brand&#227;o<sup>II</sup>; Roberto Pozzan<sup>II</sup>; Maria Eliane Campos Magalh&#227;es<sup>II</sup>; Elizabete Viana de Freitas<sup>II</sup>; Ayrton Pires Brand&#227;o<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ </p>
    <p><sup>II</sup>Faculdade de Medicina de Petr&#243;polis, Petr&#243;polis, RJ - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A velocidade da onda de pulso (VOP) pode ser marcador de comprometimento cardiovascular, por&#233;m existem poucos estudos em adultos jovens. </p>
    <p><bold>OBJETIVO: </bold> Avaliar a associa&#231;&#227;o da press&#227;o arterial (PA), vari&#225;veis antropom&#233;tricas e metab&#243;licas, atuais e obtidas 13 anos antes, na inf&#226;ncia e adolesc&#234;ncia, com a VOP. </p>
    <p><bold>M&#201;TODOS: </bold> Sessenta indiv&#237;duos foram acompanhados longitudinalmente e estratificados em dois grupos segundo o percentil da press&#227;o arterial (PA) obtido 13 anos antes: Grupo 1 (G1): percentil da PA <underline>&lt;</underline> 50 (n = 25, 11M, 26,4 anos) e Grupo 2 (G2): percentil da PA <underline>&gt;</underline> 95 (n = 35, 19M, 25,4 anos). Foram submetidos a avalia&#231;&#227;o cl&#237;nica, an&#225;lise laboratorial e medidas da VOP pelo m&#233;todo Complior. </p>
    <p><bold>RESULTADOS: </bold> G1 apresentou maior m&#233;dia de idade; G2 exibiu maior m&#233;dia de: peso, PA sist&#243;lica (PAS), PA diast&#243;lica (PAD), PA m&#233;dia (PAM), VOP e glicemia, e menor m&#233;dia de HDL-colesterol. PAS, PAM e frequ&#234;ncia card&#237;aca (FC) obtidas na inf&#226;ncia e adolesc&#234;ncia apresentaram correla&#231;&#227;o significativa com a VOP. Peso, altura, cintura, rela&#231;&#227;o cintura/quadril, PAS, PAD, press&#227;o de pulso (PP), PAM e creatinina atuais apresentaram correla&#231;&#227;o positiva e significativa com a VOP. A compara&#231;&#227;o das m&#233;dias de VOP ajustadas pela PAS, PAD, PAS e PAD, PAM e PP n&#227;o mostrou diferen&#231;a estatisticamente significativa entre os grupos. </p>
    <p><bold>CONCLUS&#195;O: </bold> O percentil da PA na inf&#226;ncia/adolesc&#234;ncia mostrou-se relacionado &#224; distensibilidade arterial, avaliada pela VOP, 13 anos ap&#243;s. Altera&#231;&#245;es da VOP podem ser identificadas em indiv&#237;duos jovens, sugerindo que o comprometimento vascular precoce pode estar presente nessa faixa et&#225;ria, relacionado tamb&#233;m a press&#227;o arterial, vari&#225;veis antropom&#233;tricas e metab&#243;licas. </p>
    <p><bold>Palavras-chave: </bold> Velocidade do fluxo sangu&#237;neo, press&#227;o arterial, &#237;ndice de massa corporal, adolescente, Brasil.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>As doen&#231;as cardiovasculares (DCV) t&#234;m origem e evolu&#231;&#227;o complexas, representando, de modo geral, a manifesta&#231;&#227;o tardia da a&#231;&#227;o de um conjunto de fatores de risco cardiovascular, de maneira isolada ou associada, que podem estar presentes em fases precoces da vida<sup>1,2</sup>.</p>
    <p>Atualmente, a hipertens&#227;o vem sendo reconhecida como uma doen&#231;a sist&#234;mica que acomete diversos &#243;rg&#227;os e sistemas, incluindo as art&#233;rias e o mioc&#225;rdio. Nesses, as anormalidades observadas incluem a disfun&#231;&#227;o endotelial, a elasticidade arterial reduzida e as altera&#231;&#245;es na estrutura e espessura da parede arterial e do ventr&#237;culo esquerdo<sup>3,4</sup>.</p>
    <p>Muita aten&#231;&#227;o vem sendo dirigida ao comportamento dos vasos arteriais, das suas propriedades mec&#226;nicas intr&#237;nsecas, neurais e hormonais dependentes do endot&#233;lio, tanto pela sua participa&#231;&#227;o na g&#234;nese da HA quanto nas consequ&#234;ncias da hipertens&#227;o sobre eles. Emerge da&#237; o grande interesse despertado nos &#250;ltimos anos, em muitos investigadores, para o estudo da rigidez arterial mediante v&#225;rios m&#233;todos, entre eles a an&#225;lise da velocidade da onda de pulso (VOP)<sup>5-7</sup>.</p>
    <p>Diversos estudos demonstram que muitas das altera&#231;&#245;es na estrutura e na fun&#231;&#227;o vascular ocorrem antes do in&#237;cio da eleva&#231;&#227;o da PA e podem mesmo ser as respons&#225;veis por sua posterior eleva&#231;&#227;o. A identifica&#231;&#227;o precoce dessas altera&#231;&#245;es e o tratamento dirigido para os mecanismos hemodin&#226;micos e n&#227;o hemodin&#226;micos da doen&#231;a, antes da eleva&#231;&#227;o da PA, podem oferecer uma melhor oportunidade de revers&#227;o do processo, reduzindo de modo mais eficaz as taxas de morbidade e mortalidade relacionadas<sup>4,8-11</sup>.</p>
    <p>Nesse contexto, diversos estudos t&#234;m-se voltado para a an&#225;lise desses fatores em faixas et&#225;rias mais jovens. O estudo de Bogalusa<sup>12-14</sup> avaliou os fatores de risco cardiovasculares gen&#233;ticos e ambientais na inf&#226;ncia e a sua contribui&#231;&#227;o no desenvolvimento da doen&#231;a estabelecida na fase adulta. No Brasil, o estudo do Rio de Janeiro<sup>15-19</sup>, do qual o presente estudo faz parte, vem demonstrando que a presen&#231;a dos fatores de risco cardiovascular ocorre j&#225; desde etapas precoces de vida e cursa com forte agrega&#231;&#227;o familiar, apontando para um cen&#225;rio de grande potencial preventivo.</p>
    <p>Assim, o objetivo desse estudo foi avaliar as vari&#225;veis que comp&#245;em os principais fatores de risco cardiovascular (tabagismo, sedentarismo, press&#227;o arterial, vari&#225;veis antropom&#233;tricas e vari&#225;veis metab&#243;licas) em uma popula&#231;&#227;o de jovens estratificados pelo percentil da press&#227;o arterial obtido 13 anos antes, na inf&#226;ncia e adolesc&#234;ncia, e buscar as poss&#237;veis associa&#231;&#245;es entre as vari&#225;veis obtidas nessa fase da vida e atualmente com a VOP.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>A amostra populacional do presente estudo foi composta por sessenta indiv&#237;duos, com idades entre 22 e 29 anos.</p>
    <p><italic>Grupo 1 <bold>-</bold></italic> Constitu&#237;do por 25 indiv&#237;duos com idade m&#233;dia de 26,40 &#177; 1,85 anos (23-29 anos), sendo 11 do sexo masculino e 14 do sexo feminino, que se situavam, 13 anos antes, no percentil da PA sist&#243;lica e diast&#243;lica igual ou menor a 50;</p>
    <p><italic>Grupo 2 <bold>-</bold></italic> Constitu&#237;do por 35 indiv&#237;duos, sendo 19 do sexo masculino e 16 do sexo feminino que se situavam, 13 anos antes, no percentil da PA sist&#243;lica e/ou diast&#243;lica igual ou maior a 95, com idade m&#233;dia de 25,40 &#177; 1,97 anos (22-29 anos).</p>
    <p>Foram analisados par&#226;metros demogr&#225;ficos, antropom&#233;tricos, cl&#237;nicos e laboratoriais. Os dois primeiros inclu&#237;ram sexo, idade em anos, peso em quilogramas (kg), altura em metros (m) e circunfer&#234;ncias do abdome e do quadril, em cent&#237;metros (cm). Foram, ainda, calculados o &#237;ndice de massa corp&#243;rea (IMC) e a rela&#231;&#227;o cintura/quadril. A classifica&#231;&#227;o de obesidade baseou-se no IMC, segundo a Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS)<sup>20</sup>. Para os valores da press&#227;o arterial foram considerados aqueles da &#250;ltima medida, de um total de tr&#234;s, em posi&#231;&#227;o supina. Os dados laboratoriais inclu&#237;ram a dosagem de colesterol total, triglicer&#237;deos, HDL-colesterol, LDL-colesterol, glicose, creatinina e &#225;cido &#250;rico. Os par&#226;metros cl&#237;nicos analisados 13 anos antes foram: peso, altura, IMC, FC, PAS, PAD, press&#227;o de pulso (PP) e percentil da press&#227;o arterial. Em rela&#231;&#227;o aos lip&#237;dios, os valores de normalidade adotados como refer&#234;ncia foram os preconizados pela IV Diretriz Brasileira sobre Dislipidemia<sup>21</sup>. Os crit&#233;rios diagn&#243;sticos, de estratifica&#231;&#227;o e de controle da hipertens&#227;o arterial seguiram a VI Diretriz Brasileira sobre Hipertens&#227;o Arterial<sup>22</sup>.</p>
    <p>Para o registro e an&#225;lise da Velocidade da Onda de Pulso (VOP), utilizou-se o sistema autom&#225;tico computadorizado Complior<sup>&#174;</sup> (Complior, Colson, Garger les Genosse, France - Createch Industrie)<sup>5</sup> (<xref ref-type="fig" rid="f1">fig. 1</xref>). Obteve-se a m&#233;dia de 10 registros para cada paciente.</p>
    <fig id="f1">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gf01.jpg"/></fig>
    <p>Em todos os testes estat&#237;sticos, fixou-se 0,05 ou 5% (p &lt; 0,05) como n&#237;vel de rejei&#231;&#227;o da hip&#243;tese de nulidade. Foram utilizados: teste do Qui-Quadrado (&#967;<sup>2</sup>) para a compara&#231;&#227;o das distribui&#231;&#245;es das vari&#225;veis de amostras independentes; teste de Mann-Whitney (Z) para a compara&#231;&#227;o das vari&#225;veis cont&#237;nuas que n&#227;o apresentaram distribui&#231;&#227;o normal a An&#225;lise de Covari&#226;ncia (F) para compara&#231;&#227;o de m&#233;dias ajustadas por outra determinada vari&#225;vel (covari&#225;vel). Foram utilizadas as vari&#225;veis de press&#227;o arterial para ajuste, pois essas t&#234;m &#237;ntima rela&#231;&#227;o com a VOP. O Teste de Correla&#231;&#227;o Bivariada de Spearman (r) foi utilizado para analisar a correla&#231;&#227;o de vari&#225;veis cont&#237;nuas com ou sem distribui&#231;&#227;o normal<sup>23</sup>.</p>
    <p>O presente estudo foi aprovado pela Comiss&#227;o de &#201;tica em Pesquisa Cl&#237;nica do Hospital Universit&#225;rio Pedro Ernesto da Universidade do Estado do Rio de Janeiro.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>A <xref ref-type="table" rid="t1">tabela 1</xref> mostra as caracter&#237;sticas demogr&#225;ficas, epidemiol&#243;gicas e antropom&#233;tricas dos 60 indiv&#237;duos avaliados. A distribui&#231;&#227;o por sexo foi homog&#234;nea nos dois grupos estudados. Os indiv&#237;duos do Grupo 1 apresentaram uma m&#233;dia de idade maior do que aqueles do Grupo 2. Assim, a compara&#231;&#227;o das m&#233;dias das vari&#225;veis antropom&#233;tricas, hemodin&#226;micas, incluindo a VOP e metab&#243;licas, foi ajustada para a idade. A an&#225;lise comparativa das vari&#225;veis antropom&#233;tricas evidenciou que os indiv&#237;duos do Grupo 2 apresentaram m&#233;dia de peso maior do que aqueles do Grupo 1. N&#227;o se observou diferen&#231;a estatisticamente significativa nas compara&#231;&#245;es das vari&#225;veis antropom&#233;tricas estudadas.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt01.jpg"/></table-wrap>
    <p>Em rela&#231;&#227;o &#224;s vari&#225;veis hemodin&#226;micas, FC, PP e preval&#234;ncia de hipertens&#227;o arterial n&#227;o apresentaram diferen&#231;as estatisticamente significativas (<xref ref-type="table" rid="t2">tab. 2</xref>).</p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt02.jpg"/></table-wrap>
    <p>As vari&#225;veis metab&#243;licas estudadas encontram-se discriminadas na <xref ref-type="table" rid="t3">tabela 3</xref>. Ao serem analisadas a glicemia de jejum e o HDL-colesterol, foi observado que a compara&#231;&#227;o das m&#233;dias mostrou diferen&#231;a estatisticamente significativa entre os grupos.</p>
    <table-wrap id="t3">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt03.jpg"/></table-wrap>
    <p>Na <xref ref-type="table" rid="t4">tabela 4</xref> encontram-se listadas as correla&#231;&#245;es da VOP com as vari&#225;veis obtidas 13 anos antes. Conforme pode ser evidenciado, houve correla&#231;&#245;es positivas e significativas da VOP com a PAS (p = 0,009), com a PAM (p = 0,019) e com a FC (p = 0,029).</p>
    <table-wrap id="t4">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt04.jpg"/></table-wrap>
    <p>Na <xref ref-type="table" rid="t5">tabela 5</xref> encontram-se listadas as correla&#231;&#245;es da VOP com as vari&#225;veis da fase atual estudadas, tendo sido observadas correla&#231;&#245;es positivas e significativas da VOP como: peso, altura, cintura, rela&#231;&#227;o cintura/quadril, PAS, PAD, PP, PAM e creatinina.</p>
    <table-wrap id="t5">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt05.jpg"/></table-wrap>
    <p>Quando as m&#233;dias da VOP foram ajustadas para idade, peso, PAS, PAD, PAM e PP (<xref ref-type="table" rid="t6">tab. 6</xref>), n&#227;o se observou diferen&#231;a significativa entre os grupos.</p>
    <table-wrap id="t6">
      <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt06.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>A relativamente recente metodologia desenvolvida para a an&#225;lise da complac&#234;ncia vascular, pela medida da VOP, tem trazido um grande avan&#231;o na pesquisa de marcadores vasculares da hipertens&#227;o arterial, sobretudo no idoso<sup>5,24-26</sup>. H&#225; pouca refer&#234;ncia, at&#233; o momento, da utiliza&#231;&#227;o da VOP como medida de comprometimento vascular em faixas et&#225;rias mais baixas. Por essa raz&#227;o, neste estudo foram avaliados indiv&#237;duos jovens, que j&#225; estavam sob acompanhamento cl&#237;nico desde a inf&#226;ncia pelo estudo do Rio de Janeiro<sup>15-19</sup>.</p>
    <p>Apesar do tamanho reduzido, a amostra avaliada no presente estudo &#233; de grande interesse, pois foi originada de uma popula&#231;&#227;o n&#227;o hospitalar, que n&#227;o sofreu nenhum tipo de interven&#231;&#227;o durante 13 anos e que vem sendo sistematicamente acompanhada e submetida a novas avalia&#231;&#245;es, permitindo a constru&#231;&#227;o do conhecimento sobre o comportamento dos fatores de risco cardiovascular nessa faixa et&#225;ria.</p>
    <p>Em rela&#231;&#227;o &#224;s vari&#225;veis demogr&#225;ficas e epidemiol&#243;gicas, os grupos estudados tiveram, com exce&#231;&#227;o da idade, todos os dados similares, sem diferen&#231;a estat&#237;stica entre eles. Os grupos apresentaram diferen&#231;a estatisticamente significativa quanto &#224;s m&#233;dias de idade, e isso poderia criar um fator de interfer&#234;ncia sobre os resultados do estudo, j&#225; que os &#237;ndices hemodin&#226;micos, metab&#243;licos e antropom&#233;tricos estudados t&#234;m, na literatura, rela&#231;&#227;o com a idade. Nesse aspecto, o fato de o grupo com percentil maior de PA (Grupo 2) ter apresentado menor m&#233;dia de idade n&#227;o poderia ser respons&#225;vel pelas diferen&#231;as observadas nas compara&#231;&#245;es das demais vari&#225;veis. Ainda assim, todas as vari&#225;veis foram ajustadas para a idade, antes da realiza&#231;&#227;o das compara&#231;&#245;es.</p>
    <p>Vale destacar, em rela&#231;&#227;o &#224;s vari&#225;veis demogr&#225;ficas e epidemiol&#243;gicas, o n&#237;tido predom&#237;nio de algumas vari&#225;veis no Grupo 2, como maiores IMC, per&#237;metros da cintura e do quadril e sobrepeso/obesidade, caracterizando resultados de import&#226;ncia cl&#237;nica mas que, provavelmente pelo pequeno n&#250;mero da amostra, n&#227;o alcan&#231;aram relev&#226;ncia estat&#237;stica.</p>
    <p>&#201; elevado o n&#237;vel de evid&#234;ncia atual da rela&#231;&#227;o do sobrepeso/obesidade, traduzido pelo aumento do IMC, com a press&#227;o arterial e com a morbidade cardiovascular<sup>1,9,10,22,27-30</sup>. Mais recentemente, a rela&#231;&#227;o cintura/quadril ou apenas a medida da cintura tem sido utilizada como marcador de obesidade central, que, por sua vez, al&#233;m de se correlacionar com a resist&#234;ncia a insulina, parece guardar melhor correla&#231;&#227;o com o risco CV do que os &#237;ndices de obesidade geral, como o IMC<sup>28</sup>.</p>
    <p>No presente estudo, o Grupo 2 apresentou menor m&#233;dia de HDL-colesterol s&#233;rico e maior m&#233;dia de glicemia de jejum, quando comparado com o Grupo 1. Ressalte-se que, apesar de estatisticamente diferentes, as m&#233;dias das glicemias de jejum se apresentaram dentro dos limites considerados como normais. Observe-se, ainda, que apesar de apenas dois indiv&#237;duos terem apresentado glicemia de jejum anormal, esses casos ocorreram no Grupo 2.</p>
    <p>&#192; exce&#231;&#227;o do HDL-colesterol, n&#227;o houve maior preval&#234;ncia de valores anormais dos n&#237;veis s&#233;ricos das outras vari&#225;veis metab&#243;licas em nenhum dos dois grupos. Os valores m&#233;dios das demais vari&#225;veis metab&#243;licas se apresentaram dentro das faixas da normalidade.</p>
    <p>J&#225; se conhece, h&#225; muito, a rela&#231;&#227;o da dislipidemia, do diabete melito e, sobretudo, da associa&#231;&#227;o de ambos, com aterosclerose e morbidade cardiovascular. De forma semelhante, a importante associa&#231;&#227;o do LDL-colesterol com risco de doen&#231;a arterial coronariana tem sido apontada em diversas s&#233;ries, tanto em indiv&#237;duos j&#225; com doen&#231;a coronariana evidente quanto naqueles sem a doen&#231;a, independentemente do sexo<sup>9,21,22,29,30</sup>. Mesmo o est&#225;gio precursor do diabete melito tipo 2, que caracteriza a intoler&#226;ncia a glicose ou a glicemia de jejum alterada, est&#225; associado com maior risco CV al&#233;m de, frequentemente, se acompanhar de situa&#231;&#245;es que habitualmente cursam em associa&#231;&#227;o com o diabetes tipo 2, como hipertrigliceridemia, baixos n&#237;veis de HDL-colesterol, maior preval&#234;ncia de hipertens&#227;o arterial, obesidade central e hiperinsulinemia, refletindo resist&#234;ncia dos tecidos perif&#233;ricos &#224; a&#231;&#227;o da insulina<sup>30,31</sup>.</p>
    <p>As observa&#231;&#245;es do estudo de Bogalusa<sup>12-14,32</sup>, que acompanhou crian&#231;as desde o nascimento at&#233; os 26 anos de idade, j&#225; indicavam que os fatores de risco cardiovascular tinham comportamento constante ao longo da inf&#226;ncia e da adolesc&#234;ncia; isso implicaria que crian&#231;as que apresentassem um perfil cardiovascular adverso (localizadas no percentil mais elevado das vari&#225;veis) poderiam estar mais sujeitas a doen&#231;a cardiovascular na fase adulta. Dentre as vari&#225;veis antropom&#233;tricas, hemodin&#226;micas e metab&#243;licas, o peso, a altura, a PAS e o LDL-colesterol foram as que apresentaram maiores coeficientes de correla&#231;&#227;o ao longo de oito anos. Esse mesmo estudo mostrou que em crian&#231;as e adolescentes entre 5 e 14 anos j&#225; havia associa&#231;&#227;o de vari&#225;veis acima do percentil 75 de PA, demonstrando com clareza a tend&#234;ncia &#224; agrega&#231;&#227;o de fatores de risco cardiovascular.</p>
    <p>Os resultados em rela&#231;&#227;o &#224;s caracter&#237;sticas antropom&#233;tricas e metab&#243;licas do presente estudo, maior peso, menor HDL-colesterolemia e maior glicemia de jejum nos indiv&#237;duos do grupo de maior percentil da PA reiteram os dados da literatura e consolidam os resultados obtidos em 1998 nesse mesmo grupo de indiv&#237;duos. J&#225; naquela &#233;poca pode ser observado que o grupo exibia maiores m&#233;dias dos &#237;ndices antropom&#233;tricos e menor m&#233;dia de HDL-colesterol, enfatizando a import&#226;ncia da presen&#231;a de sobrepeso, associada a altera&#231;&#245;es da PA, como marcadores futuros de maior PA, peso e altera&#231;&#245;es metab&#243;licas. Deve ser ressaltado que valores menores de HDL-colesterol t&#234;m sido valorizados como altera&#231;&#227;o lip&#237;dica inicial em jovens<sup>14,32</sup>.</p>
    <p>Em rela&#231;&#227;o &#224;s vari&#225;veis hemodin&#226;micas, o Grupo 2 apresentou maiores m&#233;dias da PAS, PAD, PAM e VOP. Apesar de haver maior preval&#234;ncia de indiv&#237;duos hipertensos no Grupo 2 (10 indiv&#237;duos - 28,6%) do que no Grupo 1 (4 indiv&#237;duos - 16%), n&#227;o foi observada diferen&#231;a estatisticamente significativa.</p>
    <p>O Grupo 2 apresentou m&#233;dia da VOP (8,51 m/s) significativamente maior do que aquela do Grupo 1 (7,89 m/s), sugerindo algum grau de comprometimento vascular nos indiv&#237;duos que apresentaram, na inf&#226;ncia/adolesc&#234;ncia, maior percentil da press&#227;o arterial.</p>
    <p>Diversas s&#233;ries avaliaram grupos populacionais regionais para estabelecer padr&#245;es de comportamento da VOP. Entre n&#243;s, Zilli<sup>33</sup> estudou a VOP em 463 indiv&#237;duos brasileiros saud&#225;veis. Em 204 indiv&#237;duos de ambos os sexos, na faixa et&#225;ria de 19 a 39 anos, encontrou a m&#233;dia de VOP (m&#233;todo Complior) de 8,27 &#177; 1,22 m/s. Com o mesmo objetivo, Maldonado e cols.<sup>34</sup> avaliaram 202 indiv&#237;duos portugueses normais, de ambos os sexos, que foram analisados ap&#243;s estratifica&#231;&#227;o em faixas et&#225;rias de 10 anos, a partir dos 10 anos de idade. Em 38 indiv&#237;duos da faixa et&#225;ria entre 20 e 30 anos de idade, a m&#233;dia da VOP encontrada (m&#233;todo Complior) foi de 7,52 &#177; 1,42 m/s. Houve uma tend&#234;ncia, sem significado estat&#237;stico, de maiores valores em homens, quando o grupo foi avaliado na sua totalidade.</p>
    <p>No presente estudo, as m&#233;dias da VOP foram 7,89 &#177; 1,05 m/s e 8,51 &#177; 1,04 m/s nos grupos 1 e 2, respectivamente, assemelhando-se, portanto, aos valores encontrados nos dois estudos citados antes, e mostrando-se menor do que aqueles valores do estudo de Asmar e cols.<sup>5</sup> que avaliou indiv&#237;duos com idade menor que a deste estudo<sup>5</sup>.</p>
    <p>Buscando avaliar as rela&#231;&#245;es entre as vari&#225;veis estudadas com a VOP, foram feitas, em primeiro lugar, as correla&#231;&#245;es da VOP com as vari&#225;veis antropom&#233;tricas (peso, altura e IMC) e hemodin&#226;micas (PAS, PAD, PP e FC) obtidas 13 anos antes, e pode-se observar que a FC, a PAM e, sobretudo, a PAS apresentaram correla&#231;&#227;o positiva e significativa com a VOP atual. Esse dado tem grande relev&#226;ncia, uma vez que a medida casual de PA na inf&#226;ncia e adolesc&#234;ncia foi capaz de se relacionar com a VOP obtida 13 anos depois.</p>
    <p>Em seguida foi feita a an&#225;lise da correla&#231;&#227;o da VOP com vari&#225;veis obtidas na abordagem atual do grupo e foram observadas correla&#231;&#245;es estatisticamente significativas da VOP com: peso, altura, per&#237;metro da cintura, rela&#231;&#227;o cintura/quadril, PAS, PAD, PP, PAM e creatinina.</p>
    <p>Asmar e cols.<sup>26</sup>, em estudo j&#225; referido, mostraram que os maiores determinantes da VOP foram a idade (p &lt; 0,001) e a PAS (p &lt; 0,001) em normotensos e hipertensos, n&#227;o havendo influ&#234;ncia do sexo, peso, glicemia, colesterolemia e HDL-colesterolemia. Amar e cols.<sup>24</sup> demonstraram que, numa amostra da popula&#231;&#227;o de indiv&#237;duos de alto risco para eventos CV, o ac&#250;mulo de fatores de risco foi um determinante independente de enrijecimento arterial avaliado pela VOP.</p>
    <p>A rela&#231;&#227;o da FC com a VOP &#233; controversa e ainda n&#227;o est&#225; completamente definida. Lantelme e cols.<sup>35</sup> demonstraram haver um efeito significativo e proporcional da FC sobre a VOP numa popula&#231;&#227;o de 22 indiv&#237;duos idosos.</p>
    <p>Diversos fatores gen&#233;ticos, al&#233;m daqueles respons&#225;veis diretamente sobre a fun&#231;&#227;o e a composi&#231;&#227;o dos grandes vasos arteriais, mostraram rela&#231;&#227;o com a VOP, como s&#227;o os casos daqueles que atuam sobre os cl&#225;ssicos fatores de risco cardiovascular - hipertens&#227;o arterial, dislipidemia, sensibilidade ao sal, diabete melito tipo II. Tamb&#233;m est&#225; bem identificada a rela&#231;&#227;o da VOP com a glicemia de jejum em diab&#233;ticos e em hipertensos n&#227;o tratados<sup>25</sup>.</p>
    <p>&#201; bem conhecida a correla&#231;&#227;o da VOP com o IMC em indiv&#237;duos hipertensos, assim como com a altura e a cintura abdominal em hipertensos e em portadores de insufici&#234;ncia renal grave<sup>36</sup>.</p>
    <p>O papel do metabolismo dos lip&#237;dios sobre a distensibilidade arterial n&#227;o est&#225; totalmente esclarecido e necessita maior investiga&#231;&#227;o. Na popula&#231;&#227;o geral e nos indiv&#237;duos saud&#225;veis, n&#227;o se observa correla&#231;&#227;o da distensibilidade arterial com o colesterol total, observa-se correla&#231;&#227;o com o HDL-colesterol, e a rela&#231;&#227;o com o LDL-colesterol ainda &#233; controversa. N&#227;o se observaram, at&#233; o momento, resultados que possam ser generalizados sobre a rela&#231;&#227;o da distensibilidade arterial com os n&#237;veis dos lip&#237;dios em indiv&#237;duos hipertensos<sup>25</sup>.</p>
    <p>Como pode ser observado dos estudos citados que avaliaram a VOP em indiv&#237;duos jovens, seus resultados foram semelhantes aos encontrados no presente estudo, ou seja, a associa&#231;&#227;o de diversas vari&#225;veis que comp&#245;em os fatores de risco CV com a VOP. De forma semelhante, as diferen&#231;as das m&#233;dias da VOP ajustadas para idade, peso e vari&#225;veis hemodin&#226;micas tornaram a compara&#231;&#227;o das m&#233;dias de VOP entre os dois grupos sem significado estat&#237;stico, possivelmente demonstrando a participa&#231;&#227;o dessas vari&#225;veis no determinismo da VOP. Apesar de a VOP n&#227;o poder ser identificada como uma vari&#225;vel independente de diferen&#231;a entre os grupos, a sua associa&#231;&#227;o com diversas vari&#225;veis cardiovasculares constitui um perfil desfavor&#225;vel de fatores de risco de um grupo de indiv&#237;duos jovens estratificado por uma vari&#225;vel obtida 13 anos antes.</p>
    <p>Assim, a avalia&#231;&#227;o da VOP em indiv&#237;duos jovens parece permitir a identifica&#231;&#227;o precoce do processo de acometimento vascular associado a altera&#231;&#245;es iniciais da PA. A perspectiva preventiva para as DCV relacionadas &#224;s faixas et&#225;rias mais jovens coloca a medida da VOP como um m&#233;todo relevante, pois se configura potencialmente como um marcador de les&#227;o vascular.</p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>No presente estudo foi demonstrado que o percentil da PA na inf&#226;ncia/adolesc&#234;ncia p&#244;de influenciar a distensibilidade arterial, avaliada pela VOP obtida 13 anos ap&#243;s. Esse comportamento permite sugerir que o comprometimento vascular, traduzido por essa vari&#225;vel, pode surgir precocemente; entretanto, ser&#227;o necess&#225;rios mais estudos para determinar a import&#226;ncia da VOP como fator de predi&#231;&#227;o de morbidade e de mortalidade nessa faixa et&#225;ria.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Oswaldo Luiz Pizzi.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Roberto Pozzan </p>
        <p> Rua das Margaridas, 108 - Itacoatiara </p>
        <p> 24348-220 - Niter&#243;i, RJ - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="rpozzan@cardiol.br">rpozzan@cardiol.br</email>, </p>
        <p>
          <email xlink:href="rpozzan@globo.com">rpozzan@globo.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 18/10/10; revisado recebido em 11/11/10; aceito em 08/02/11.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. 2003 World Health    Organization (WHO)/International Society of Hypertension (ISH) statement on    management of hypertension. Whitworth JA; WHO/ISH Writing Group. J Hypertens.    2003;21(11):1983-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>statement on management of hypertension</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1983</fpage>
          <lpage>92</lpage>
          <issue>11</issue>
          <volume>21</volume>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Ram CV. The    evolving definition of systemic hypertension. Am J Cardiol. 2007;99(8):1168-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The evolving definition of systemic hypertension</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1168</fpage>
          <lpage>70</lpage>
          <issue>8</issue>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ram</surname>
              <given-names>CV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Cohn JN. Arteries,    myocardium, blood pressure and cardiovascular risk: towards a revised definition    of hypertension. J Hypertens. 1998;16(Pt 2): 2.117-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Arteries, myocardium, blood pressure and cardiovascular risk: towards a revised definition of hypertension</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>2.117</fpage>
          <lpage>24</lpage>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Giles TD, Berk    BC, Black HR, Cohn JN, Kostis JB, Izzo Jr JL, et al. Expanding the definition    and classification of hypertension. J Clin Hypertens. 2005;7(9):505-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Expanding the definition and classification of hypertension</article-title>
          <source>J Clin Hypertens</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>505</fpage>
          <lpage>12</lpage>
          <issue>9</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Giles</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Kostis</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Izzo Jr</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Asmar R, Benetos    A, London G, Hugue C, Weiss Y, Topouchian J, et al. Aortic distensibility in    normotensive, untreated and treated hypertensive patients. Blood Press. 1995;4(1):48-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aortic distensibility in normotensive, untreated and treated hypertensive patients</article-title>
          <source>Blood Press</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>48</fpage>
          <lpage>54</lpage>
          <issue>1</issue>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Benetos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>London</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hugue</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Topouchian</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Safar ME. Arteries    in clinical hypertension. Philadelphia: Lippincot-Raven; 1996.</mixed-citation>
        <element-citation publication-type="book">
          <source>Arteries in clinical hypertension</source>
          <date>
            <year>1996</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Safar</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Safar ME, London    GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension.    Hypertension. 1998;32(1):156-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Recent advances on large arteries in hypertension</article-title>
          <source>Hypertension</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>156</fpage>
          <lpage>61</lpage>
          <issue>1</issue>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Safar</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>London</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Frohlich</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Cohn JN. Arterial    stiffness, vascular disease, and risk of cardiovascular events. Circulation.    2006;113(5):601-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Arterial stiffness, vascular disease, and risk of cardiovascular events</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>601</fpage>
          <lpage>3</lpage>
          <issue>5</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Conroy RM, Py&#246;r&#228;l&#228;    K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year    risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart    J. 2003;24(11):987-1003.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>987</fpage>
          <lpage>1003</lpage>
          <issue>11</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Conroy</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Py&#246;r&#228;l&#228;</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fitzgerald</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Sans</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Menotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Backer</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Emberson J,    Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population    and high-risk strategies for the primary prevention of cardiovascular disease.    Eur Heart J. 2004;25(6):484-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>484</fpage>
          <lpage>91</lpage>
          <issue>6</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Emberson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whincup</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ebrahim</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Neutel JM,    Smith DHG, Weber MA. Is high blood pressure a late manifestation of the hypertension    syndrome? Am J Hypertens. 1999;12(12 Pt 3):215S-23S.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Is high blood pressure a late manifestation of the hypertension syndrome?</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>215S</fpage>
          <lpage>23S</lpage>
          <issue>12</issue>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Neutel</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DHG</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Berenson GS.    Childhood risk factors predict adult risk associated with subclinical cardiovascular    disease. The Bogalusa Heart Study. Am J Cardiol. 2002;90(10):3L-7L.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: The Bogalusa Heart Study</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>3L</fpage>
          <lpage>7L</lpage>
          <issue>10</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Berenson GS,    Srnivasan SR. Cardiovascular risk factors in youth with implications for aging:    the Bogalusa Heart Study. Neurobiol Aging. 2005;26(3):303-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study</article-title>
          <source>Neurobiol Aging</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>303</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srnivasan</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Berenson GS,    Wattigney WA, Tracy RE, Newman WP 3rd, Srinivasan SR, Webber LS, et al. Atherosclerosis    of the aorta and coronary arteries and cardiovascular risk factors in persons    aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J    Cardiol. 1992;70(9):851-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study)</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>851</fpage>
          <lpage>8</lpage>
          <issue>9</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Wattigney</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Tracy</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Newman WP</surname>
              <given-names>3rd</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Webber</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Brand&#227;o    AA, Pozzan R, Albanesi FMF, Brand&#227;o AP. Role of anthropometric indexes    and blood pressure as determinants of left ventricular mass and geometry in    adolescents: the Rio de Janeiro Study. Hypertension. 1995;26(6 Pt 2):1190-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Role of anthropometric indexes and blood pressure as determinants of left ventricular mass and geometry in adolescents: the Rio de Janeiro Study</article-title>
          <source>Hypertension</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1190</fpage>
          <lpage>4</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Albanesi</surname>
              <given-names>FMF</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Brand&#227;o    AP, Brand&#227;o AA, Ara&#250;jo EM, Oliveira RC. Familial aggregation of    arterial blood pressure and possible genetic influence. Hypertension. 1992;19(Suppl    2):214 -7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Familial aggregation of arterial blood pressure and possible genetic influence</article-title>
          <source>Hypertension</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>214 </fpage>
          <lpage>7</lpage>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Magalh&#227;es    ME, Pozzan R, Brand&#227;o AA, Cerqueira RC, Roussoulieres AL, Szwarcwald    C, et al. Early blood pressure level as a mark of familial aggregation of metabolic    cardiovascular risk factors - The Rio de Janeiro Study. J Hypertens. 1998;16(12    Pt 2):1885 -9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors - The Rio de Janeiro Study</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1885 </fpage>
          <lpage>9</lpage>
          <issue>12</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Magalh&#227;es</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Roussoulieres</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Szwarcwald</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Pozzan R, Brand&#227;o    AA, Brand&#227;o AP. Early involvement of left ventricle in adolescents with    upper percentile of blood pressure - The Rio de Janeiro Study [Abstract].    J Am Coll Cardiol. 1996;27(Suppl A):105A-106A.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early involvement of left ventricle in adolescents with upper percentile of blood pressure - The Rio de Janeiro Study [Abstract]</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>105A</fpage>
          <lpage>106A</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Pozzan R, Brand&#227;o    AA, da Silva SLD, Brand&#227;o AP. Hyperglycemia, hyperinsulinemia, overweight,    and high blood pressure in young adults: the Rio de Janeiro Study. Hypertension.    1997;30(3 Pt 2):650-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hyperglycemia, hyperinsulinemia, overweight, and high blood pressure in young adults: the Rio de Janeiro Study</article-title>
          <source>Hypertension</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>650</fpage>
          <lpage>3</lpage>
          <issue>3</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>SLD</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Obesity: preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ Tech Rep Ser 2000;894:i-x11,1-253.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity: preventing and managing the global epidemic</article-title>
          <source>World Health Organ Tech Rep Ser</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>i</fpage>
          <volume>894</volume>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Sposito AC,    Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al; Sociedade    Brasileira de Cardiologia. IV Diretrizes brasileiras sobre dislipidemias e preven&#231;&#227;o    da aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de    Cardiologia. Arq Bras Cadiol. 2007;88(supl 1):2-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretrizes brasileiras sobre dislipidemias e preven&#231;&#227;o da aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia</article-title>
          <source>Arq Bras Cadiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2</fpage>
          <lpage>19</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sposito</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Caramelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Bertolami</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Afiune Neto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Sociedade Brasileira    de Cardiologia / Sociedade Brasileira de Hipertens&#227;o / Sociedade Brasileira    de Nefrologia. VI Diretrizes brasileiras de hipertens&#227;o arterial. Arq    Bras Cardiol. 2010;95(sup 1):1-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>VI Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>1</fpage>
          <lpage>51</lpage>
          <volume>95</volume>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Vieira S. Introdu&#231;&#227;o    &#224; bioestat&#237;stica. 3&#350; ed. Rio de Janeiro: Campus; 1980.</mixed-citation>
        <element-citation publication-type="book">
          <source>Introdu&#231;&#227;o &#224; bioestat&#237;stica</source>
          <date>
            <year>1980</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Vieira</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Amar J, Ruidavets    JB, Chamontin B, Drouet L, Ferri&#232;res J. Arterial stiffness and cardiovascular    risk factors in a population-based study. J Hypertens. 2001;19(3):381-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Arterial stiffness and cardiovascular risk factors in a population-based study</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>381</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Amar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ruidavets</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Chamontin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Drouet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferri&#232;res</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Asmar R. History.    In: Arterial stiffness and pulse wave velocity: clinical applications. Paris:    Elsevier; 1999. p. 9-10.</mixed-citation>
        <element-citation publication-type="book">
          <source>Arterial stiffness and pulse wave velocity: clinical applications</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>9</fpage>
          <lpage>10</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Asmar RG, Benetos    A, Topouchian JP, Laurent P, Pannier B, Brisac AM, et al. Assesment of arterial    distensibility by automatic pulse wave velocity measurement. Validation and    clinical application studies. Hypertension. 1995;26(3):485-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assesment of arterial distensibility by automatic pulse wave velocity measurement: Validation and clinical application studies</article-title>
          <source>Hypertension</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>485</fpage>
          <lpage>90</lpage>
          <issue>3</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Asmar</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Benetos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Topouchian</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Laurent</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pannier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brisac</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Chobanian AV,    Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The National High    Blood Pressure Education Program Coordinating C. Seventh Report of the Joint    National Committee on Prevention, Detection, Evaluation, and Treatment of High    Blood Pressure. Hypertension. 2003;42(6):1206-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The National High Blood Pressure Education Program Coordinating C: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>
          <source>Hypertension</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1206</fpage>
          <lpage>52</lpage>
          <issue>6</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chobanian</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bakris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Izzo JL</surname>
              <given-names>Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Kotseva K,    Wood D, De Backer G, De Bacquer D, Py&#246;r&#228;l&#228; K, Keil U. Cardiovascular    prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and    III surveys in eight European countries. Lancet. 2009;373(9667):929-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries</article-title>
          <source>Lancet</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>929</fpage>
          <lpage>40</lpage>
          <issue>9667</issue>
          <volume>373</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kotseva</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>De Backer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Bacquer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Py&#246;r&#228;l&#228;</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Keil</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. M&#252;ller-Nordhorn    J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular    mortality within Europe. Eur Heart J. 2008;29(10):1316-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An update on regional variation in cardiovascular mortality within Europe</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1316</fpage>
          <lpage>26</lpage>
          <issue>10</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>M&#252;ller-Nordhorn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Binting</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roll</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Willich</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30. Sociedade Brasileira de Diabetes. Diretrizes 2007. Tratamento e acompanhamento do diabetes mellitus. [Acesso em 2010 nov 10]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.anad.org.br/profissionais/images/diretrizes_SBD_2007.pdf">http://www.anad.org.br/profissionais/images/diretrizes_SBD_2007.pdf</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Diretrizes 2007: Tratamento e acompanhamento do diabetes mellitus</source>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Graham I, Atar    D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines    on cardiovascular disease prevention in clinical practice: executive summary.    Eur Heart J. 2007;28(19):2375-414.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>European guidelines on cardiovascular disease prevention in clinical practice: executive summary</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2375</fpage>
          <lpage>414</lpage>
          <issue>19</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Graham</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Atar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Borch-Johnsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boysen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Burell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cifkova</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Berenson GS,    Srinivisan SR, Hunter SM, Nicklas TA, Freedman DS, Shear CL, et al. Risk factors    in early life as predictors of adult heart disease: the Bogalusa Heart Study.    Am J Med Sci. 1989;298(3):141-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study</article-title>
          <source>Am J Med Sci</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>141</fpage>
          <lpage>51</lpage>
          <issue>3</issue>
          <volume>298</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srinivisan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Nicklas</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Shear</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Zilli EC. Estudo    da varia&#231;&#227;o da velocidade da onda de pulso em uma amostra populacional    de indiv&#237;duos sadios estratificados pela faixa et&#225;ria [Disserta&#231;&#227;o].    Rio de Janeiro: Universidade do Estado do Rio de Janeiro (UERJ); 2002.</mixed-citation>
        <element-citation publication-type="thesis">
          <source>Estudo da varia&#231;&#227;o da velocidade da onda de pulso em uma amostra populacional de indiv&#237;duos sadios estratificados pela faixa et&#225;ria</source>
          <date>
            <year>2002</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Zilli</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Maldonado J,    Pego M, Barbosa A, Pereira T, Asmar R, Teixeira F, et al. Normalcy patterns    of aortic distensibility in a Portuguese population. Am J Hypertens. 2000;13:205A.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Normalcy patterns of aortic distensibility in a Portuguese population</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>205A</fpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maldonado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pego</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Lantelme P,    Mestre C, Lievre M, Gressard A, Milon H. Heart rate: an important confounder    of pulse wave velocity assessment. Hypertension. 2002;39(6):1083-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart rate: an important confounder of pulse wave velocity assessment</article-title>
          <source>Hypertension</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1083</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lantelme</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mestre</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lievre</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gressard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Milon</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Najjar SS,    Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, et al. Pulse wave velocity    is an independent predictor of the longitudinal increase in systolic blood pressure    and of incident hypertension in the Baltimore Longitudinal Study of Aging. J    Am Coll Cardiol. 2008;51(14):1377-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1377</fpage>
          <lpage>83</lpage>
          <issue>14</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Najjar</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Scuteri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shetty</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Fleg</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Pulse wave vocity in young adults: study of Rio de Janeiro</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Pulse wave velocity (PWV) can be a marker of cardiovascular impairment, but there are few studies in young adults. OBJECTIVE: To evaluate the association between blood pressure (BP), current anthropometric and metabolic variables and those obtained 13 years earlier, in childhood and adolescence, with PWV. METHODS: Sixty individuals were followed longitudinally and split into two groups according to the percentile of blood pressure (BP) obtained 13 years earlier: Group 1 (G1): BP percentile &lt; 50 (n = 25, 11M, 26.4 years old) and Group 2 (G2): BP &gt; 95 percentile (n = 35, 19M, 25.4 years old). The individuals underwent clinical evaluation, laboratory analysis and measurements of PWV through the Complior method. RESULTS: G1 showed higher mean age; G2 showed greater mean weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), PWV and blood glucose, and lower mean HDL-cholesterol. SBP, MAP and heart rate (HR) obtained during childhood and adolescence significantly correlated with PWV. Current weight, height, waist-hip ratio, SBP, DBP, pulse pressure (PP), MAP and creatinine presented a positive and significant correlation with PWV. A comparison of the average PWV adjusted for SBP, DBP, SBP and DBP, MAP and PP showed no statistically significant difference between groups. CONCLUSION: The percentile of BP in childhood/adolescence related to arterial distensibility assessed by PWV 13 years later. Changes in PWV can be identified in young individuals suggesting that early vascular impairment may be present in this age group, also related to blood pressure, anthropometric and metabolic variables.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Blood flow velocity</kwd>
        <kwd>blood pressure</kwd>
        <kwd>body mass index</kwd>
        <kwd>adolescent</kwd>
        <kwd>Brazil</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Pulse wave velocity in young adults. Study of Rio de Janeiro</bold>
          </label>
          <p>
            <bold>Oswaldo Luiz Pizzi<sup>I</sup>; Andr&#233;a Araujo Brand&#227;o<sup>II</sup>; Roberto Pozzan<sup>II</sup>; Maria Eliane Campos Magalh&#227;es<sup>II</sup>; Elizabete Viana de Freitas<sup>II</sup>; Ayrton Pires Brand&#227;o<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ</p>
      <p><sup>II</sup>Faculdade de Medicina de Petr&#243;polis, Petr&#243;polis, RJ - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Pulse wave velocity (PWV) can be a marker of cardiovascular impairment, but there are few studies in young adults.</p>
      <p><bold>OBJECTIVE: </bold> To evaluate the association between blood pressure (BP), current anthropometric and metabolic variables and those obtained 13 years earlier, in childhood and adolescence, with PWV.</p>
      <p><bold>METHODS: </bold> Sixty individuals were followed longitudinally and split into two groups according to the percentile of blood pressure (BP) obtained 13 years earlier: Group 1 (G1): BP percentile <underline>&lt;</underline> 50 (n = 25, 11M, 26.4 years old) and Group 2 (G2): BP <underline>&gt;</underline> 95 percentile (n = 35, 19M, 25.4 years old). The individuals underwent clinical evaluation, laboratory analysis and measurements of PWV through the Complior method.</p>
      <p><bold>RESULTS: </bold> G1 showed higher mean age; G2 showed greater mean weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), PWV and blood glucose, and lower mean HDL-cholesterol. SBP, MAP and heart rate (HR) obtained during childhood and adolescence significantly correlated with PWV. Current weight, height, waist-hip ratio, SBP, DBP, pulse pressure (PP), MAP and creatinine presented a positive and significant correlation with PWV. A comparison of the average PWV adjusted for SBP, DBP, SBP and DBP, MAP and PP showed no statistically significant difference between groups.</p>
      <p><bold>CONCLUSION: </bold> The percentile of BP in childhood/adolescence related to arterial distensibility assessed by PWV 13 years later. Changes in PWV can be identified in young individuals suggesting that early vascular impairment may be present in this age group, also related to blood pressure, anthropometric and metabolic variables.</p>
      <p><bold>Keywords:</bold> Blood flow velocity; blood pressure; body mass index; adolescent; Brazil.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Cardiovascular diseases (CVD) have complex origin and evolution, representing, in general, the late manifestation of the action of a set of cardiovascular risk factors, either alone or associated, which may be present early in life<sup>1,2</sup>.</p>
      <p>Currently, hypertension has been recognized as a systemic disease affecting multiple organs and systems, including the arteries and the heart. In these, the abnormalities observed include endothelial dysfunction, reduced arterial elasticity and changes in structure and thickness of the arterial wall and left ventricle<sup>3,4</sup>.</p>
      <p>Much attention has been directed to the behavior of arteries, their intrinsic mechanical, neural and hormonal endothelium-dependent properties, due to their participation in the genesis of hypertension and in the consequences of hypertension on them. Hence the great interest of many researchers in the study of arterial stiffness through various methods, including the analysis of pulse wave velocity (PWV)<sup>5-7</sup>.</p>
      <p>Several studies show that many of the changes in vascular structure and function occur before the onset of increased blood pressure and may be even responsible for its subsequent rise. Early identification and treatment of these changes and treatment directed towards the hemodynamic and non hemodynamic mechanisms of the disease, before the increase of BP, may offer a better chance of reversing the process, more effectively reducing the morbidity and mortality rates<sup>4,8-11</sup>.</p>
      <p>In this context, several studies have focused on the analysis of these factors in younger age groups. The Bogalusa<sup>12-14</sup> study evaluated genetic and environmental cardiovascular risk factors in childhood and their contribution to the development of established disease in adulthood. In Brazil, the study of Rio de Janeiro<sup>15-19</sup>, which this present study is part of, has shown that the presence of cardiovascular risk factors occurs since the early stages of life and progresses with strong familial aggregation, pointing to a scenario of great preventive potential.</p>
      <p>Thus, the purpose of this study is to evaluate the variables that make up the main cardiovascular risk factors (smoking, sedentary lifestyle, blood pressure, anthropometric and metabolic variables) in a young population stratified by percentiles of blood pressure obtained 13 years later, in childhood and adolescence, and to search for possible associations between the variables obtained in this phase of life and currently with the PWV.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The sample population of this study was composed of sixty individuals, aged between 22 and 29 years.</p>
      <p><italic>Group 1 -</italic> Consisting of 25 individuals with a mean age of 26.40 &#177; 1.85 years (23-29 years old), 11 males and 14 females, which stood, 13 years earlier, in the percentile of systolic and diastolic BP equal or smaller than 50;</p>
      <p><italic>Group 2 -</italic> Consisting of 35 individuals, 19 males and 16 females, which stood, 13 years earlier, in the percentile of systolic and/or diastolic BP equal or smaller than 95, with mean age of 25.40 &#177; 1.97 years (22-29 years old).</p>
      <p>Demographic, anthropometric, clinical and laboratory parameters were analyzed. The first two included gender, age in years, weight in kilograms (kg), height in meters (m) and abdominal circumference and hip circumference in centimeters (cm). Body mass index (BMI) and waist/hip ratio were also calculated. The classification of obesity was based on BMI, according to the World Health Organization (WHO)<sup>20</sup>. For the blood pressure values, those of the last measure, out of three in the supine position were considered. Laboratory data included the measurement of total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, glucose, creatinine and uric acid. Clinical parameters analyzed 13 years earlier were: height, weight, BMI, HR, SBP, DBP, pulse pressure (PP) and percentile of blood pressure. Regarding lipids, normal values adopted as a reference were those recommended by the 4<sup>th</sup> Brazilian Guidelines on Dyslipidemia<sup>21</sup>. Diagnostic, stratification, and control criteria of hypertension followed the 6<sup>th</sup> Brazilian Guidelines on Hypertension<sup>22</sup>.</p>
      <p>To record and analyze pulse wave velocity (PWV), we used the automatic computerized system Complior&#153; (Complior, Colson, Garges les Genosse, France - Createch Industrie)<sup>5</sup> (<xref ref-type="fig" rid="f1-body2">Fig. 1</xref>). We obtained an average of 10 records for each patient.</p>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gf01-en.jpg"/></fig>
      <p>In all statistical tests, 0.05 or 5% (p &lt; 0.05) was established as a rejection level of null hypothesis. The following were used: chi-square test (&#967;<sup>2</sup>) to compare the distributions of the variables in independent samples; Mann-Whitney test (Z) to compare continuous variables without normal distribution; analysis of covariance (F) to compare adjusted means by another variable (covariate). Blood pressure variables were used for adjustment, because these are closely related to PWV. Spearman's Bivariate Correlation Test (r) was used to analyze the correlation of continuous variables with or without normal distribution<sup>23</sup>.</p>
      <p>This study was approved by the Ethics in Clinical Research, <italic>Hospital Universit&#225;rio Pedro Ernesto</italic>, <italic>Universidade do Estado do Rio de Janeiro</italic>.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p><xref ref-type="table" rid="t1-body2">Table 1</xref> shows the demographic, epidemiological and anthropometric characteristics of the 60 individuals evaluated. Gender distribution was homogeneous in both groups. Individuals in Group 1 had an average age higher than those in Group 2. Thus, the comparison of the average of anthropometric and hemodynamic variables, including PWV and metabolic variables, was adjusted for age. The comparative analysis of the anthropometric variables showed that the individuals of Group 2 had a mean weight higher than those in Group 1. There was no statistically significant difference in the comparisons of the anthropometric variables studied.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt01-en.jpg"/></table-wrap>
      <p>As for hemodynamics, HR, PP and prevalence of hypertension showed no statistically significant differences (<xref ref-type="table" rid="t2-body2">table 2</xref>).</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt02-en.jpg"/></table-wrap>
      <p>The metabolic variables studied are described in <xref ref-type="table" rid="t3-body2">Table 3</xref>. Analysis of fasting glucose and HDL-cholesterol revealed that the comparison of averages showed a statistically significant difference between groups.</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt03-en.jpg"/></table-wrap>
      <p><xref ref-type="table" rid="t4-body2">Table 4</xref> lists the correlations of PWV with the variables obtained 13 years earlier. There were positive and significant correlations of PWV with SBP (p = 0.009), with MAP (p = 0.019) and HR (p = 0.029).</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt04-en.jpg"/></table-wrap>
      <p><xref ref-type="table" rid="t5-body2">Table 5</xref> lists the correlations of PWV with the variables studied in the current stage, and positive and significant correlations of PWV were observed, such as: weight, height, waist-hip ratio, SBP, DBP, PP, MAP and creatinine.</p>
      <table-wrap id="t5-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt05-en.jpg"/></table-wrap>
      <p>When the mean PWV were adjusted for age, weight, SBP, DBP, MAP and PP (<xref ref-type="table" rid="t6-body2">Table 6</xref>), there was no significant difference between groups.</p>
      <table-wrap id="t6-body2">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt06-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The relatively recent methodology developed for the analysis of vascular compliance, measured by PWV, has brought a major breakthrough in research of vascular markers of hypertension, especially in the elderly<sup>5,24-26</sup>. So far, there have been few references on the use of PWV as a measure of vascular damage in younger individuals. Therefore, this study evaluated young individuals who had been under clinical follow-up since childhood in the study of Rio de Janeiro<sup>15-19</sup>.</p>
      <p>Despite the small size, the sample evaluated in this study is of great interest because it was derived from a non-hospital population, which has not had any type of intervention for 13 years and has been systematically monitored and subjected to further evaluations, allowing the construction of knowledge on the behavior or cardiovascular risk factors in this age group.</p>
      <p>As for demographic and epidemiological variables, except for age, the groups had all similar data, with no statistical difference between them. The groups showed a statistically significant difference as for mean age, and this could create an interference factor on the results of the study, since the hemodynamic, metabolic and anthropometric parameters studied are, in the literature, related to age. In this respect, the fact that the group with higher BP percentile (Group 2) has shown a lower average age could not account for the differences observed in the comparisons of other variables. Still, all variables were adjusted for age, prior to the comparisons.</p>
      <p>It is worth noting, in relation to demographic and epidemiological variables, the clear predominance of some variables in Group 2, such as higher BMI, waist-to-hip ratio and overweight/obesity, characterizing results of clinical importance but, probably due to small sample size, it has not reached any statistical relevance.</p>
      <p>There is a high level of current evidence of the relationship of overweight/obesity, translated by increased BMI, with blood pressure and cardiovascular morbidity<sup>1,9,10,22,27-30</sup>. More recently, waist-hip ratio or waist circumference alone has been used as a marker of central obesity, which, in turn, in addition to correlating with insulin resistance, appears to correlate better with CV risk than general obesity indexes such as BMI<sup>28</sup>.</p>
      <p>In this study, Group 2 had lower mean HDL-cholesterol and higher mean fasting glucose compared with Group 1. It should be noted that, although statistically different, the mean fasting glucose was within the limits considered normal. Note also that although only two individuals have shown abnormal fasting glucose, these cases occurred in Group 2.</p>
      <p>Except for HDL-cholesterol, none of the groups had a higher prevalence of abnormal values of serum levels of other metabolic variables. The average values of the other metabolic variables are within the ranges of normality.</p>
      <p>The relationship of dyslipidemia, diabetes mellitus, and especially the combination of both with atherosclerosis and cardiovascular morbidity has been long known. Similarly, the significant association of LDL-cholesterol with risk of coronary artery disease has been reported in several series, both in individuals with evident coronary artery disease as those without the disease, regardless of gender<sup>9,21,22,29,30</sup>. Even the earliest stage of diabetes mellitus type 2, which characterizes impaired glucose tolerance or impaired fasting glucose, is associated with increased CV risk and has often been accompanied by situations that usually occur concomitantly in association with type 2 diabetes, such as hypertriglyceridemia, low levels of HDL-cholesterol, higher prevalence of hypertension, central obesity and hyperinsulinemia, reflecting resistance of peripheral tissues to insulin action<sup>30,31</sup>.</p>
      <p>The observations of the study of Bogalusa<sup>12-14,32</sup>, which followed children from birth to 26 years of age, have indicated that cardiovascular risk factors had a constant behavior throughout childhood and adolescence; this would imply that children who had an adverse cardiovascular profile (located at the highest percentile of the variables) might be more prone to cardiovascular diseases in adulthood. Among the anthropometric, hemodynamic and metabolic variables, weight, height, SBP and LDL-cholesterol showed the highest correlation coefficients over eight years. This study showed that in children and adolescents aged between 5 and 14 years, there had been an association of variables above the 75<sup>th</sup> percentile of BP, clearly demonstrating the tendency for aggregation of cardiovascular risk factors.</p>
      <p>The results in relation to the anthropometric and metabolic characteristics of this study, higher weight, lower HDL-cholesterol and higher fasting glucose levels in the individuals of the group at the highest percentile of BP confirm literature data and corroborate the results obtained in 1998 in the same group of individuals. At that time, the group had higher mean anthropometric indexes and lower mean HDL-cholesterol, emphasizing the importance of the presence of overweight associated with changes in BP, as future markers of higher BP, weight and metabolic changes. It should be noted that lower values of HDL-cholesterol have been valued as initial lipid change in young adults<sup>14,32</sup>.</p>
      <p>As for hemodynamics, Group 2 had higher mean SBP, DBP, MAP and PWV. Although there is a higher prevalence of hypertensive individuals in Group 2 (10 individuals - 28.6%) than in Group 1 (4 individuals - 16%) there was no statistically significant difference.</p>
      <p>Group 2 had a mean of PWV (8.51 m/s) significantly higher than that of Group 1 (7.89 m/s), suggesting some degree of vascular impairment in individuals who presented in childhood/adolescence a higher percentile of arterial pressure.</p>
      <p>Several series have evaluated regional population groups to establish standards of PWV behavior. In Brazil, Zilli<sup>33</sup> studied PWV in 463 healthy Brazilian individuals. In 204 individuals of both sexes, aged 19-39 years, he found an average PWV (Complior method) of 8.27 &#177; 1.22 m/s. With the same objective, Maldonado et al<sup>34</sup> evaluated 202 normal Portuguese individuals of both sexes, who were analyzed after stratification by age group of 10 years from 10 years of age. In 38 individuals aged 20-30 years, the average PWV (Complior method) was 7.52 &#177; 1.42 m/s. There was a trend without statistical significance of higher levels in men, when the group was evaluated in its entirety.</p>
      <p>In this study, the mean PWV was 7.89 &#177; 1.05 m/s and 8.51 &#177; 1.04 m/s in groups 1 and 2, respectively, resembling thus the values found in the two studies cited before, and showing lower values than those of the study by Asmar et al<sup>5</sup>, which assessed individuals younger than those included in this study<sup>5</sup>.</p>
      <p>Seeking to evaluate the relationships between the variables studied with PWV, correlations of PWV were drawn with the anthropometric variables (weight, height and BMI) and hemodynamic variables (SBP, DBP, PP and HR) obtained 13 years earlier, and it can be observed that HR, MAP, and especially SBP showed a positive and significant correlation with the current PWV. This data is greatly relevant, since the casual measurement of BP in childhood and adolescence was able to relate with the PWV obtained 13 years later.</p>
      <p>Then, the correlation of PWV with those variables derived from the current approach of the group was analyzed and statistically significant correlations of PWV were observed with weight, height, waist circumference, waist-hip ratio, SBP, DBP, PP, MAP and creatinine.</p>
      <p>Asmar et al<sup>26</sup>, in a study cited above, showed that the major determinants of PWV were age (p &lt; 0.001) and SBP (p &lt; 0.001) in normotensive and hypertensive patients, and there is no influence of sex, weight, blood glucose, cholesterol and HDL-cholesterol. Amar et al<sup>24</sup> have shown that in a sample of individuals at high risk for CV events, the accumulation of risk factors was an independent determinant of arterial stiffness assessed by PWV.</p>
      <p>The relationship of HR with PWV is controversial and not yet fully defined. Lantelme et al<sup>35</sup> showed that there is a significant and proportional effect of HR on PWV in a population of 22 elderly individuals.</p>
      <p>Several genetic factors, besides those directly responsible for the function and composition of the great arteries, showed a relationship with PWV, such as are the cases of those acting on the classical CV risk factors - hypertension, dyslipidemia, salt sensitivity, diabetes mellitus type II. The relationship of PWV with fasting glucose levels in untreated diabetic and hypertensive patients has been well identified<sup>25</sup>.</p>
      <p>The correlation of PWV with BMI in hypertensive individuals, as well as the height and waist circumference in hypertensive patients and those with severe renal failure is well known<sup>36</sup>.</p>
      <p>The role of lipid metabolism on arterial distensibility is not completely understood and needs further investigation. In the general population and in healthy individuals, no correlation is observed in arterial distensibility with total cholesterol, there is a correlation with HDL-cholesterol, and the relationship with LDL-cholesterol is controversial. So far, results that can be generalized on the relationship between arterial distensibility and lipid levels in hypertensive individuals have not been observed<sup>25</sup>.</p>
      <p>As it can be seen in the studies that evaluated PWV in young individuals, their results were similar to those found in this study, i.e., association of several variables that make up the CV risk factors with PWV. Similarly, the mean differences of PWV adjusted for age, weight, and hemodynamic variables made the comparison of average PWV between the two groups to be devoid of statistical significance, possibly demonstrating the involvement of these variables in the determination of PWV. Although PWV cannot be identified as an independent variable of difference between the groups, its association with various cardiovascular variables constitutes an adverse profile of risk factors for a group of young individuals stratified by a variable obtained 13 years earlier.</p>
      <p>Thus, the assessment of PWV in young adults seems to allow the early identification of the process of vascular involvement associated with early changes in BP. A preventive approach to CVD related to younger age groups places the measurement of PWV as a relevant method, because it is a potential marker of vascular injury.</p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>Our study has shown that the percentile of BP in childhood/adolescence could influence arterial distensibility, assessed by PWV obtained after 13 years. This behavior suggests that vascular involvement, translated by this variable, may appear early; however, further studies are needed to determine the significance of PWV as a predictor of morbidity and mortality in this age group.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Oswaldo Luiz Pizzi.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">La velocidad de la onda de pulso en j&#243;venes: estudio de Rio de Janeiro</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La velocidad de la onda de pulso (VOP), puede ser un marcador de compromiso cardiovascular, aunque existen pocos estudios en adultos j&#243;venes. OBJETIVO: Evaluar la asociaci&#243;n de la presi&#243;n arterial (PA), variables antropom&#233;tricas y metab&#243;licas actuales y tambi&#233;n obtenidas 13 a&#241;os antes, en la infancia y en la adolescencia, con la VOP. M&#201;TODOS: Sesenta individuos fueron seguidos longitudinalmente y estratificados en dos grupos seg&#250;n el percentil de la presi&#243;n arterial (PA) obtenido 13 a&#241;os antes: Grupo 1(G1): percentil de la PA &lt; 50 (n = 25, 11M, 26,4 a&#241;os) y Grupo 2 (G2): percentil de la PA &gt; 95 (n = 35, 19M, 25,4 a&#241;os). Fueron sometidos a evaluaci&#243;n cl&#237;nica, an&#225;lisis laboratorial y medidas de la VOP por el m&#233;todo Complior. RESULTADOS: G1 present&#243; un promedio mayor de edad; G2 mostr&#243; un promedio mayor de: peso, PA sist&#243;lica (PAS), PA diast&#243;lica (PAD), PA promedio (PAP), VOP y glucemia, y menor promedio de HDL-colesterol. La PAS, PAP y la frecuencia card&#237;aca (FC), obtenidas en la infancia y en la adolescencia presentaron una correlaci&#243;n significativa con la VOP. El peso, altura, cintura, relaci&#243;n cintura/cadera, PAS, PAD, la presi&#243;n de pulso (PP), PAP y la creatinina actuales, presentaron una correlaci&#243;n positiva y significativa con la VOP. La comparaci&#243;n de los promedios de VOP ajustados por las PAS, PAD, PAS y PAD, PAP y PP no arroj&#243; ninguna diferencia estad&#237;sticamente significativa entre los grupos. CONCLUSI&#211;N: El percentil de la PA en la infancia/adolescencia tuvo una relaci&#243;n con la distensibilidad arterial, evaluada por la VOP, 13 a&#241;os despu&#233;s. Las alteraciones de la VOP pueden ser identificadas en individuos j&#243;venes, sugiriendo que el compromiso vascular en edad temprana, puede estar presente en esa franja etaria, relacionando tambi&#233;n la presi&#243;n arterial, las variables antropom&#233;tricas y metab&#243;licas.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Velocidad del flujo sangu&#237;neo</kwd>
        <kwd>presi&#243;n arterial</kwd>
        <kwd>&#237;ndice de masa corporal</kwd>
        <kwd>adolescente</kwd>
        <kwd>Brasil</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>La velocidad de la onda de pulso en j&#243;venes. Estudio de Rio de Janeiro</bold>
          </label>
          <p>
            <bold>Oswaldo Luiz Pizzi<sup>I,II</sup>; Andr&#233;a Araujo Brand&#227;o<sup>I</sup>; Roberto Pozzan<sup>I</sup>; Maria Eliane Campos Magalh&#227;es<sup>I</sup>; Elizabete Viana de Freitas<sup>I</sup>; Ayrton Pires Brand&#227;o<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ</p>
      <p><sup>II</sup>Faculdade de Medicina de Petr&#243;polis, Petr&#243;polis, RJ - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> La velocidad de la onda de pulso (VOP), puede ser un marcador de compromiso cardiovascular, aunque existen pocos estudios en adultos j&#243;venes.</p>
      <p><bold>OBJETIVO:</bold> Evaluar la asociaci&#243;n de la presi&#243;n arterial (PA), variables antropom&#233;tricas y metab&#243;licas actuales y tambi&#233;n obtenidas 13 a&#241;os antes, en la infancia y en la adolescencia, con la VOP.</p>
      <p><bold>M&#201;TODOS:</bold> Sesenta individuos fueron seguidos longitudinalmente y estratificados en dos grupos seg&#250;n el percentil de la presi&#243;n arterial (PA) obtenido 13 a&#241;os antes: Grupo 1(G1): percentil de la PA <underline>&lt;</underline> 50 (n = 25, 11M, 26,4 a&#241;os) y Grupo 2 (G2): percentil de la PA <underline>&gt;</underline> 95 (n = 35, 19M, 25,4 a&#241;os). Fueron sometidos a evaluaci&#243;n cl&#237;nica, an&#225;lisis laboratorial y medidas de la VOP por el m&#233;todo Complior.</p>
      <p><bold>RESULTADOS:</bold> G1 present&#243; un promedio mayor de edad; G2 mostr&#243; un promedio mayor de: peso, PA sist&#243;lica (PAS), PA diast&#243;lica (PAD), PA promedio (PAP), VOP y glucemia, y menor promedio de HDL-colesterol. La PAS, PAP y la frecuencia card&#237;aca (FC), obtenidas en la infancia y en la adolescencia presentaron una correlaci&#243;n significativa con la VOP. El peso, altura, cintura, relaci&#243;n cintura/cadera, PAS, PAD, la presi&#243;n de pulso (PP), PAP y la creatinina actuales, presentaron una correlaci&#243;n positiva y significativa con la VOP. La comparaci&#243;n de los promedios de VOP ajustados por las PAS, PAD, PAS y PAD, PAP y PP no arroj&#243; ninguna diferencia estad&#237;sticamente significativa entre los grupos.</p>
      <p><bold>CONCLUSI&#211;N:</bold> El percentil de la PA en la infancia/adolescencia tuvo una relaci&#243;n con la distensibilidad arterial, evaluada por la VOP, 13 a&#241;os despu&#233;s. Las alteraciones de la VOP pueden ser identificadas en individuos j&#243;venes, sugiriendo que el compromiso vascular en edad temprana, puede estar presente en esa franja etaria, relacionando tambi&#233;n la presi&#243;n arterial, las variables antropom&#233;tricas y metab&#243;licas. (Arq Bras Cardiol 2011; 97(1):53-58)</p>
      <p><bold>Palabras clave:</bold> Velocidad del flujo sangu&#237;neo, presi&#243;n arterial, &#237;ndice de masa corporal, adolescente, Brasil.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Las enfermedades cardiovasculares (ECV) se originan y evolucionan con complejidad representando, de manera general, la manifestaci&#243;n tard&#237;a de la acci&#243;n de un conjunto de factores de riesgo CV, de manera aislada o asociada, que pueden estar presentes en fases tempranas de la vida<sup>1,2</sup>.</p>
      <p>Actualmente, la hipertensi&#243;n ha venido siendo reconocida como una enfermedad sist&#233;mica que afecta a diversos &#243;rganos y sistemas, incluyendo las arterias y el miocardio. En esos &#243;rganos, las anormalidades observadas incluyen la disfunci&#243;n endotelial, la elasticidad arterial reducida y las alteraciones en la estructura y en el grosor de la pared arterial y del ventr&#237;culo izquierdo<sup>3,4</sup>.</p>
      <p>Tambi&#233;n se le ha dado mucha atenci&#243;n al comportamiento de los vasos arteriales, sus propiedades mec&#225;nicas intr&#237;nsecas, neurales y hormonales dependientes del endotelio, tanto por su participaci&#243;n en la g&#233;nesis de la HA como en las consecuencias de la hipertensi&#243;n sobre ellos. Es ah&#237; de donde surge el gran inter&#233;s en los &#250;ltimos a&#241;os en muchos investigadores, por estudiar la rigidez arterial mediante varios m&#233;todos, entre ellos, el an&#225;lisis de la velocidad de la onda de pulso (VOP)<sup>5-7</sup>.</p>
      <p>Diversos estudios demuestran que muchas de las alteraciones en la estructura y en la funci&#243;n vascular se dan antes del inicio de la elevaci&#243;n de la PA y pueden de hecho ser las causantes de su posterior elevaci&#243;n. La identificaci&#243;n temprana de esas alteraciones y el tratamiento dirigido para los mecanismos hemodin&#225;micos y no hemodin&#225;micos de la enfermedad, antes de la elevaci&#243;n de la PA, pueden ofrecer una mejor oportunidad de reversi&#243;n del proceso, reduciendo de modo m&#225;s eficaz las tasas de morbilidad y mortalidad relacionadas<sup>4,8-11</sup>.</p>
      <p>En ese sentido, diversos estudios han sido dirigidos hacia el an&#225;lisis de esos factores en franjas etarias m&#225;s j&#243;venes. El estudio de Bogalusa<sup>12-14</sup> evalu&#243; los factores de riesgo cardiovasculares gen&#233;ticos y ambientales en la infancia y su aporte al desarrollo de la enfermedad establecida en la fase adulta. En Brasil, el estudio de Rio de Janeiro<sup>15-19</sup>, (del cual el presente estudio forma parte), ha venido demostrando que la presencia de los FR cardiovascular, ocurre desde etapas tempranas de la vida y cursa con una fuerte agregaci&#243;n familiar, lo que nos indica un escenario de gran potencial preventivo.</p>
      <p>El objetivo es este estudio, fue evaluar las variables que componen los principales factores de riesgo cardiovascular (tabaquismo, sedentarismo, presi&#243;n arterial, variables antropom&#233;tricas y variables metab&#243;licas), en una poblaci&#243;n de j&#243;venes estratificados por el percentil de la presi&#243;n arterial obtenido 13 a&#241;os antes, en la infancia y en la adolescencia, y buscar las posibles asociaciones entre las variables obtenidas en esa fase de la vida y en la actualidad con la VOP.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>La muestra poblacional del presente estudio estuvo compuesta por sesenta individuos, con edades entre los 22 y los 29 a&#241;os.</p>
      <p><italic>Grupo 1 -</italic> Constituido por 25 individuos con edad promedio de 26,40 &#177; 1,85 a&#241;os (23-29 a&#241;os), siendo 11 del sexo masculino y 14 del sexo femenino, que se ubicaban 13 a&#241;os antes, en el percentil de la PA sist&#243;lica y diast&#243;lica igual o menor a 50.</p>
      <p><italic>Grupo 2 -</italic> Constituido por 35 individuos, siendo 19 del sexo masculino y 16 del sexo femenino que se ubicaban 13 a&#241;os antes, en el percentil de la PA sist&#243;lica y/o diast&#243;lica igual o mayor a 95, con una edad promedio de 25,40 &#177; 1,97 a&#241;os (22-29 a&#241;os).</p>
      <p>Fueron analizados los par&#225;metros demogr&#225;ficos, antropom&#233;tricos, cl&#237;nicos y laboratoriales. Los dos primeros incluyeron el sexo, la edad en a&#241;os, peso en kilogramos (kg), altura en metros (m) y circunferencias del abdomen y de la cadera, en cent&#237;metros (cm). Tambi&#233;n se calcul&#243; el &#237;ndice de masa corporal (IMC), y la relaci&#243;n cintura/cadera. La clasificaci&#243;n de obesidad estuvo basada en el IMC, seg&#250;n la Organizaci&#243;n Mundial de la Salud (OMS)<sup>20</sup>. Para los valores de la presi&#243;n arterial fueron considerados los de la &#250;ltima medida, de un total de tres, en posici&#243;n supina. Los datos laboratoriales incluyeron la dosificaci&#243;n de colesterol total, triglic&#233;ridos, HDL-colesterol, LDL-colesterol, glucosa, creatinina y &#225;cido &#250;rico. Los par&#225;metros cl&#237;nicos analizados 13 a&#241;os antes fueron: peso, altura, IMC, FC, PAS, PAD, presi&#243;n de pulso (PP) y percentil de la presi&#243;n arterial. Con relaci&#243;n a los l&#237;pidos, los valores de normalidad adoptados como referente fueron los preconizados por la IV Directriz Brasile&#241;a sobre Dislipidemia<sup>21</sup>. Los criterios diagn&#243;sticos de estratificaci&#243;n y de control de la hipertensi&#243;n arterial secundaron la VI Directriz Brasile&#241;a sobre Hipertensi&#243;n Arterial<sup>22</sup>.</p>
      <p>Para el registro y el an&#225;lisis de la Velocidad de la Onda de Pulso (VOP), usamos el sistema autom&#225;tico computadorizado Complior<sup>&#174;</sup> (Complior, Colson, Garger les Genosse, Francia - Createch Industrie)<sup>5</sup> (<xref ref-type="fig" rid="fig1-body3">fig. 1</xref>), obteni&#233;ndose el promedio de 10 registros para cada paciente.</p>
      <fig id="fig1-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gf01-es.jpg"/></fig>
      <p>En todos los test estad&#237;sticos se fij&#243; un 0,05 o un 5% (p &lt; 0,05) como nivel de rechazo de la hip&#243;tesis de nulidad. Se usaron: el teste del Xi-Cuadrado (Xi<sup>2</sup>), para la comparaci&#243;n de las distribuciones de las variables de muestras independientes; test de Mann-Whitney (Z) para la comparaci&#243;n de las variables continuas que no presentaron una distribuci&#243;n normal, y el An&#225;lisis de Covariancia (F) para la comparaci&#243;n de los promedios ajustados por otra variable determinada (covariable). Se usaron las variables de presi&#243;n arterial para el ajuste, porque ellas posen una &#237;ntima relaci&#243;n con la VOP. El Test de Correlaci&#243;n Bivariada de Spearman (r) fue utilizado para analizar la correlaci&#243;n de las variables continuas con o sin distribuci&#243;n normal<sup>23</sup>.</p>
      <p>El presente estudio fue aprobado por la Comisi&#243;n de &#201;tica en Investigaci&#243;n Cl&#237;nica del Hospital Universitario Pedro Ernesto de la Universidad del Estado de Rio de Janeiro.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>La <xref ref-type="table" rid="tab1-body3">tabla 1</xref> muestra las caracter&#237;sticas demogr&#225;ficas, epidemiol&#243;gicas y antropom&#233;tricas de los 60 individuos evaluados. La distribuci&#243;n por sexo fue homog&#233;nea en los dos grupos estudiados. Los individuos del Grupo 1 presentaron un promedio de edad m&#225;s elevado que los del Grupo 2. Por lo tanto, la comparaci&#243;n de los promedios de las variables antropom&#233;tricas, hemodin&#225;micas, incluyendo la VOP y metab&#243;licas se ajust&#243; para la edad. El an&#225;lisis comparativo de las variables antropom&#233;tricas mostr&#243; que los individuos del Grupo 2 presentaron un promedio de peso mayor que aquellos del Grupo 1. No se observ&#243; diferencia estad&#237;sticamente significativa en las comparaciones de las variables antropom&#233;tricas estudiadas.</p>
      <table-wrap id="tab1-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt01-es.jpg"/></table-wrap>
      <p>Con relaci&#243;n a las variables hemodin&#225;micas, FC, PP y prevalencia de hipertensi&#243;n arterial, no presentaron diferencias estad&#237;sticamente significativas (<xref ref-type="table" rid="tab2-body3">tabla 2</xref>).</p>
      <table-wrap id="tab2-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt02-es.jpg"/></table-wrap>
      <p>Las variables metab&#243;licas estudiadas aparecen desglosadas en la <xref ref-type="table" rid="tab3-body3">tabla 3</xref>. Cuando se analizaron la glucemia en ayunas y el HDL-colesterol, fue observado que la comparaci&#243;n de los promedios arroj&#243; una diferencia estad&#237;sticamente significativa entre los grupos.</p>
      <table-wrap id="tab3-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt03-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="tab4-body3">tabla 4</xref> est&#225;n desglosadas las correlaciones de la VOP con las variables obtenidas 13 a&#241;os antes. Como se ve, hubo correlaciones positivas y significativas de la VOP con la PAS (p = 0,009), con la PAP (p = 0,019) y con la FC (p = 0,029).</p>
      <table-wrap id="tab4-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt04-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="tab5-body3">tabla 5</xref> est&#225;n desglosadas las correlaciones de la VOP con las variables de la fase actual estudiadas, y se han observado las correlaciones positivas y significativas de la VOP como: peso, altura, cintura, relaci&#243;n cintura/cadera, PAS, PAD, PP, PAP y creatinina.</p>
      <table-wrap id="tab5-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt05-es.jpg"/></table-wrap>
      <p>Cuando los promedios de la VOP fueron ajustados para la edad, peso, PAS, PAD, PAP y PP (<xref ref-type="table" rid="tab6-body3">tabla 6</xref>), no se observ&#243; ninguna diferencia significativa entre los grupos.</p>
      <table-wrap id="tab6-body3">
        <graphic xlink:href="1678-4170-abc-97-01-0053-00067-gt06-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>La relativa y reciente metodolog&#237;a desarrollada para el an&#225;lisis de la complacencia vascular por la medida de la VOP, ha tra&#237;do un gran avance para la investigaci&#243;n de los marcadores vasculares de la hipertensi&#243;n arterial, sobre todo en el paciente anciano<sup>5,24-26</sup>. Existen pocos referentes hasta ahora, de la utilizaci&#243;n de la VOP como medida de compromiso vascular en edades m&#225;s j&#243;venes. Por esa raz&#243;n, en este estudio, se evaluaron individuos j&#243;venes que ya estaban bajo seguimiento cl&#237;nico desde la infancia por medio del estudio de Rio de Janeiro<sup>15-19</sup>.</p>
      <p>A pesar del reducido tama&#241;o, la muestra evaluada en este estudio es de gran inter&#233;s, porque se origin&#243; en una poblaci&#243;n no hospitalaria, que no sufri&#243; ning&#250;n tipo de intervenci&#243;n durante 13 a&#241;os y que ha venido siendo sistem&#225;ticamente seguida y sometida a nuevas evaluaciones, permitiendo la construcci&#243;n del conocimiento sobre el comportamiento de los factores de riesgo cardiovascular en esa franja etaria.</p>
      <p>Con relaci&#243;n a las variables demogr&#225;ficas y epidemiol&#243;gicas, los grupos estudiados alcanzaron con excepci&#243;n de la edad, todos los datos similares, sin diferencia estad&#237;stica entre ellos. Los grupos presentaron una diferencia estad&#237;sticamente significativa en cuanto a los promedios de edad, y eso podr&#237;a crear un factor de interferencia sobre los resultados del estudio, ya que los &#237;ndices hemodin&#225;micos, metab&#243;licos y antropom&#233;tricos estudiados poseen una relaci&#243;n con la edad en la literatura. En ese aspecto, el hecho de que el grupo con un percentil mayor de PA (Grupo 2) haya tenido un menor promedio de edad, no podr&#237;a ser el responsable de las diferencias observadas en las comparaciones de las dem&#225;s variables. Pero incluso as&#237;, todas las variables fueron ajustadas para la edad antes de la realizaci&#243;n de las comparaciones.</p>
      <p>Con relaci&#243;n a las variables demogr&#225;ficas y epidemiol&#243;gicas, vale destacar el n&#237;tido predominio de algunas variables en el Grupo 2, como mayor IMC, per&#237;metros de la cintura y de la cadera y sobrepeso/obesidad, caracterizando los resultados de importancia cl&#237;nica pero que, tal vez en funci&#243;n del reducido n&#250;mero de la muestra, no obtuvieron una relevancia estad&#237;stica.</p>
      <p>Es elevado el nivel de evidencia actual de la relaci&#243;n del sobrepeso/obesidad, traducido por el aumento del IMC, con la presi&#243;n arterial y con la morbilidad cardiovascular<sup>1,9,10,22,27-30</sup>. Recientemente, la relaci&#243;n cintura/cadera o solamente la medida de la cintura, ha sido utilizada como un marcador de obesidad central que, a su vez, adem&#225;s de correlacionarse con la resistencia a la insulina, parece tener una mejor correlaci&#243;n con el riesgo CV que con los indicadores de obesidad general, como el IMC<sup>28</sup>.</p>
      <p>En el presente estudio, el Grupo 2 obtuvo un menor promedio de HDL-colesterol s&#233;rico y un mayor promedio de glucemia en ayunas cuando se compar&#243; con el Grupo 1. En bueno resaltar que a pesar de que sean estad&#237;sticamente diferentes, los promedios de las glucemias en ayunas estuvieron dentro de los l&#237;mites considerados como normales. Tambi&#233;n observamos que a pesar de que apenas dos individuos hayan presentado glucemia en ayunas anormal, esos casos ocurrieron en el Grupo 2.</p>
      <p>Con excepci&#243;n del HDL-colesterol, no hubo una mayor prevalencia de valores anormales de los niveles s&#233;ricos de las otras variables metab&#243;licas en ninguno de los dos grupos. Los valores promedios de las dem&#225;s variables metab&#243;licas estuvieron dentro de la normalidad.</p>
      <p>Ya sabemos hace mucho tiempo, la existencia de la relaci&#243;n de la dislipidemia, de la diabetes Mellitus y sobre todo, de la asociaci&#243;n de ambos con la arterioesclerosis y la morbilidad cardiovascular. A semejanza de eso, la importante asociaci&#243;n del LDL-colesterol con el riesgo de enfermedad arterial coronaria, ha sido indicada en diversas series, tanto en individuos que ya tienen la enfermedad coronaria evidente como en los que no la tienen, independientemente del sexo<sup>9,21,22,29,30</sup>. Incluso el estadio precursor de la diabetes mellitus del tipo 2, que caracteriza la intolerancia a la glucosa o a la glucemia en ayunas alterada, est&#225; asociado a un mayor riesgo CV adem&#225;s de que a menudo est&#233; acompa&#241;ado de situaciones que habitualmente cursan con una asociaci&#243;n de la diabetes tipo 2, como la hipertrigliceridemia, bajos niveles de HDL-colesterol, mayor prevalencia de hipertensi&#243;n arterial, obesidad central e hiperinsulinemia, reflejando una resistencia de los tejidos perif&#233;ricos a la acci&#243;n de la insulina<sup>30,31</sup>.</p>
      <p>Las observaciones del estudio de Bogalusa<sup>12-14,32</sup>, que hizo un seguimiento en ni&#241;os desde su nacimiento hasta los 26 a&#241;os de edad, ya nos indicaban que los factores de riesgo cardiovascular ten&#237;an un comportamiento constante a lo largo de la infancia y de la adolescencia. Eso conllevar&#237;a a que los ni&#241;os que presentasen un perfil cardiovascular adverso (ubicados en el percentil m&#225;s elevado de las variables), podr&#237;an estar m&#225;s propensos a la enfermedad cardiovascular en la fase adulta. Entre las variables antropom&#233;tricas, hemodin&#225;micas y metab&#243;licas, el peso, la altura, la PAS y el LDL-colesterol, fueron las que presentaron mayores coeficientes de correlaci&#243;n a lo largo de ocho a&#241;os. Ese mismo estudio mostr&#243; que en ni&#241;os y adolescentes entre los 5 y los 14 a&#241;os, ya exist&#237;a una asociaci&#243;n de variables por encima del percentil 75 de PA, lo que indicaba claramente la tendencia a la agregaci&#243;n de factores de riesgo cardiovascular.</p>
      <p>Los resultados con relaci&#243;n a las caracter&#237;sticas antropom&#233;tricas y metab&#243;licas del presente estudio, mayor peso, menor HDL-colesterolemia y una mayor glucemia en ayunas en los individuos del grupo de mayor percentil de la PA, refuerzan los datos de la literatura y consolidan los resultados obtenidos en 1998 en ese mismo grupo de individuos. Ya en aquella &#233;poca, se observaba que el grupo ten&#237;a mayores promedios de los &#237;ndices antropom&#233;tricos y un menor promedio de HDL-colesterol, enfatizando la importancia de la presencia de sobrepeso asociada a las alteraciones de la PA, como marcadores futuros de mayor PA, peso y alteraciones metab&#243;licas. Debemos destacar tambi&#233;n que los valores menores de HDL-colesterol han sido valorados como alteraci&#243;n lip&#237;dica inicial en j&#243;venes<sup>14,32</sup>.</p>
      <p>Con relaci&#243;n a las variables hemodin&#225;micas, el Grupo 2 present&#243; mayores promedios de la PAS, PAD, PAP y VOP. A pesar de existir una mayor prevalencia de individuos hipertensos en el Grupo 2 (10 individuos - 28,6%) que en el Grupo 1 (4 individuos - 16%), no se observ&#243; una diferencia estad&#237;sticamente significativa.</p>
      <p>El Grupo 2 present&#243; un promedio de la VOP (8,51 m/s) significativamente mayor que el del Grupo 1 (7,89 m/s), indicando alg&#250;n grado de compromiso vascular en los individuos que tuvieron en la infancia/adolescencia, un mayor percentil de la presi&#243;n arterial.</p>
      <p>Diversas series evaluaron grupos de poblaci&#243;n regionales para establecer est&#225;ndares de comportamiento de la VOP. Entre nosotros, Zilli<sup>33</sup> estudi&#243; la VOP en 463 individuos brasile&#241;os sanos. En 204 individuos de ambos sexos, con una franja etaria de 19 a 39 a&#241;os, encontr&#243; el promedio de VOP (m&#233;todo Complior) de 8,27 &#177; 1,22 m/s. Con el mismo objetivo, Maldonado et al<sup>34</sup> evaluaron 202 individuos portugueses normales, de ambos sexos, que se analizaron despu&#233;s de la estratificaci&#243;n en edades de 10 a&#241;os, y a partir de los 10 a&#241;os de edad. En 38 individuos entre los 20 y los 30 a&#241;os de edad, el promedio de la VOP encontrada (m&#233;todo Complior), fue de 7,52 &#177; 1,42 m/s. Hubo una tendencia sin significado estad&#237;stico, de mayores valores en los hombres, cuando el grupo fue evaluado en su totalidad.</p>
      <p>En el presente estudio, los promedios de la VOP fueron 7,89 &#177; 1,05 m/s y 8,51 &#177; 1,04 m/s en los grupos 1 y 2 respectivamente, asemej&#225;ndose por lo tanto, a los valores encontrados en los dos estudios citados anteriormente, e indicando un menor valor que aquellos valores del estudio de Asmar et al<sup>5</sup> que evaluaron a individuos con una edad menor que la de este estudio<sup>5</sup>.</p>
      <p>Buscando calcular las relaciones entre las variables estudiadas con la VOP, se hicieron, en primer lugar, las correlaciones de la VOP con las variables antropom&#233;tricas (peso, altura e IMC), y hemodin&#225;micas (PAS, PAD, PP y FC), obtenidas 13 a&#241;os antes, y pudimos observar que la FC, la PAP y principalmente la PAS, presentaron una correlaci&#243;n positiva y significativa con relaci&#243;n a la VOP actual. Ese dato posee una gran relevancia porque la medida casual de PA en la infancia y la adolescencia fue capaz de relacionarse con la VOP obtenida 13 a&#241;os despu&#233;s.</p>
      <p>Enseguida se realiz&#243; el an&#225;lisis de la correlaci&#243;n de la VOP con las variables obtenidas en el abordaje actual del grupo y fueron observadas correlaciones estad&#237;sticamente significativas de la VOP respecto al peso, la altura, el per&#237;metro de la cintura, la relaci&#243;n cintura/cadera, PAS, PAD, PP, PAP y creatinina.</p>
      <p>Asmar et al<sup>26</sup>, en un estudio ya referido anteriormente, demostraron que los mayores determinantes de la VOP fueron la edad (p &lt; 0,001) y la PAS (p &lt; 0,001) en normotensos e hipertensos, no habiendo una influencia del sexo, peso, glucemia, colesterolemia y HDL-colesterolemia. Amar et al<sup>24</sup> demostraron que, en una muestra de la poblaci&#243;n de individuos de alto riesgo para eventos CV, la acumulaci&#243;n de factores de riesgo fue un determinante independiente de rigidez arterial evaluado por la VOP.</p>
      <p>La relaci&#243;n de la FC con la VOP es algo controvertido y todav&#237;a no est&#225; completamente definida. Lantelme et al<sup>35</sup> demostraron que existe un efecto significativo y proporcional de la FC sobre la VOP en una poblaci&#243;n de 22 individuos ancianos.</p>
      <p>Diversos factores gen&#233;ticos, adem&#225;s de los que son responsables directos de la funci&#243;n y la composici&#243;n de los grandes vasos arteriales, indicaron una relaci&#243;n con la VOP, como son los casos de los que act&#250;an sobre los cl&#225;sicos factores de riesgo CV - hipertensi&#243;n arterial, dislipidemia, sensibilidad a la sal, y diabetes mellitus tipo II. Tambi&#233;n est&#225; bien identificada la relaci&#243;n de la VOP con la glucemia en ayunas en los diab&#233;ticos y en los hipertensos no tratados<sup>25</sup>.</p>
      <p>La correlaci&#243;n de la VOP con el IMC en los individuos hipertensos es bien conocida, como tambi&#233;n con la altura y la cintura abdominal en los hipertensos y en los portadores de insuficiencia renal grave<sup>36</sup>.</p>
      <p>El papel del metabolismo de los l&#237;pidos sobre la distensibilidad arterial no est&#225; totalmente aclarado y necesita ser m&#225;s investigado. En la poblaci&#243;n general y en los individuos sanos, no se observa una correlaci&#243;n de la distensibilidad arterial con el colesterol total, pero s&#237; que se observa una correlaci&#243;n con el HDL-colesterol, y la relaci&#243;n con el LDL-colesterol todav&#237;a es algo controvertido. No fueron observados hasta el momento, resultados que puedan ser generales sobre la relaci&#243;n de la distensibilidad arterial con los niveles de los l&#237;pidos en los individuos hipertensos<sup>25</sup>.</p>
      <p>Como puede observarse en los estudios citados que evaluaron la VOP en individuos j&#243;venes, sus resultados fueron parecidos con los encontrados en el presente estudio, lo que indica una asociaci&#243;n de diversas variables que componen los factores de riesgo CV con la VOP. Igualmente, las diferencias de los promedios de la VOP ajustadas para la edad, el peso y las variables hemodin&#225;micas dejaron la comparaci&#243;n de los promedios de VOP entre los dos grupos sin significado estad&#237;stico, tal vez demostrando la participaci&#243;n de esas variables en el determinismo de la VOP. A pesar de que la VOP no puede ser identificada como una variable independiente de la diferencia entre los grupos, su asociaci&#243;n con diversas variables cardiovasculares constituye un perfil no favorable de factores de riesgo de un grupo de individuos j&#243;venes estratificado por una variable obtenida 13 a&#241;os antes.</p>
      <p>Por lo tanto, la evaluaci&#243;n de la VOP en individuos j&#243;venes parece permitir la identificaci&#243;n temprana del proceso de afectaci&#243;n vascular asociado a las alteraciones iniciales de la PA. La perspectiva preventiva para las ECV relacionadas con las franjas etarias m&#225;s j&#243;venes pone la medida de la VOP como un m&#233;todo relevante, porque se configura potencialmente como un marcador de lesi&#243;n vascular.</p>
      <p>
        <bold>Conclusiones</bold>
      </p>
      <p>En el presente estudio qued&#243; demostrado que el percentil de la PA en la infancia/adolescencia influy&#243; en la distensibilidad arterial, evaluada por la VOP obtenida 13 a&#241;os despu&#233;s. Ese comportamiento nos indica que el compromiso vascular traducido por esa variable, puede surgir en edades tempranas. Sin embargo, ser&#225;n necesarios m&#225;s estudios para determinar la importancia de la VOP como un factor de predicci&#243;n de morbilidad y de mortalidad en esa franja etaria.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de Disertaci&#243;n de Maestr&#237;a de Oswaldo Luiz Pizzi, por la <italic>Universidade do Estado do Rio de Janeiro</italic>.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
